Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: CD5L-associated gene analyses highlight the dysregulations, prognostic effects, immune associations, and drug-sensitivity predicative potentials of LCAT and CDC20 in hepatocellular carcinoma

Fig. 2

Identification of CD5L-AGs in HCC. A–B Gene expression comparisons between CD5Lhigh and CD5Llow HCC samples in TCGA-HCC dataset and ICGC-HCC dataset, respectively. C CD5L-AGs which were both enriched in CD5L-associated pathways and higher expressed in CD5Lhigh HCC samples. D CD5L-AGs which were both enriched in CD5L-associated pathways and lower expressed in CD5Lhigh HCC samples. CD5L-AGs, CD5L-associated genes; HCC, hepatocellular carcinoma. “Limma” package in R were used for gene comparisons and adjusted p < 0.05 was considered significant

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us